Comparative study of effect of valsartan 160mg treatment versus continuous positive airway pressure on arterial blood pressure in patients who have an obstructive sleep apnea syndrome and a weak or moderate hypertension.

Trial Profile

Comparative study of effect of valsartan 160mg treatment versus continuous positive airway pressure on arterial blood pressure in patients who have an obstructive sleep apnea syndrome and a weak or moderate hypertension.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 19 Sep 2010

At a glance

  • Drugs Valsartan (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms VALSAS
  • Most Recent Events

    • 03 Jun 2010 Results published in the American journal of respiratory and critical care medicine.
    • 16 May 2010 Results in 23 patients have been presented at the 106th International Conference of the American Thoracic Society.
    • 31 Oct 2009 Results in 25 patients were published as an abstract in the proceedings of the 75th Annual Meeting of the American College of Chest Physicians: Chest 2009, 31 Oct 2009.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top